Table 3. Multivariate analysis for factors associated with relapse-free survival in patients treated with taxane–trastuzumab neoadjuvant chemotherapy (n=58).

	Multivariate HR	95% CI	P
Age (years)
⩾50	1
<50	1.75	0.37–8.22	0.47
Oestrogen receptor
Positive	1
Negative	1.88	0.51–7.14	0.34
T-bet+ infiltrates after CT
Yes	1
No	4.76	1.07–20	0.04

Abbreviations: CI=confidence interval; CT=chemotherapy; HR=hazard ratio.